NCT06107361 Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
| NCT ID | NCT06107361 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Corewell Health East |
| Condition | Peripheral Intravenous Vein Catheter Phlebitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2023-11-07 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2023-11-07 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Eligibility Criteria
Study Participants Inclusion Criteria: ≥ than 18 years old Vascular Access Score of 4 or 5 Vascular Access Score: 1. Visible with distention and easily palpable 2. Visible and easily palpable 3. Not visible and easily palpable 4. Visible and poorly palpable 5. Not visible and poorly or non-palpable Study participants exclusion criteria: \<18 years old Restricted mobility of elbow joint Cognitively impaired. Skin complications that limit access to the potential IV site Clinician Participants Inclusion Criteria: Clinician working in the emergency department at Corewell Health William Beaumont University Hospital (physician, advanced practice provider, nurse, technician) Competency in Operation STICK, which is an vascular access training program. Clinician participants exclusion criteria: None
Contact & Investigator
Amit Bahl, MD
PRINCIPAL INVESTIGATOR
Corewell Health East
Frequently Asked Questions
Who can join the NCT06107361 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peripheral Intravenous Vein Catheter Phlebitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06107361 currently recruiting?
Yes, NCT06107361 is actively recruiting participants. Contact the research team at amit.bahl@corewellhealth.org for enrollment information.
Where is the NCT06107361 trial being conducted?
This trial is being conducted at Royal Oak, United States.
Who is sponsoring the NCT06107361 clinical trial?
NCT06107361 is sponsored by Corewell Health East. The principal investigator is Amit Bahl, MD at Corewell Health East. The trial plans to enroll 360 participants.